DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,254 filers reported holding DANAHER CORPORATION in Q3 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,780,957 | +17.9% | 132,128 | +14.1% | 0.27% | +24.3% |
| Q2 2023 | $27,797,520 | -0.7% | 115,823 | +4.2% | 0.22% | -9.2% |
| Q1 2023 | $28,006,181 | +95178.6% | 111,118 | +0.3% | 0.24% | -3.6% |
| Q4 2022 | $29,394 | -99.9% | 110,745 | +15.6% | 0.25% | 0.0% |
| Q3 2022 | $24,735,000 | +3.6% | 95,763 | +1.6% | 0.25% | -2.4% |
| Q2 2022 | $23,886,000 | -4.4% | 94,218 | +10.7% | 0.26% | +3.2% |
| Q1 2022 | $24,976,000 | -4.9% | 85,145 | +6.7% | 0.25% | -10.2% |
| Q4 2021 | $26,264,000 | +8.3% | 79,826 | +0.3% | 0.28% | -2.5% |
| Q3 2021 | $24,240,000 | +13.6% | 79,623 | +0.1% | 0.28% | +18.5% |
| Q2 2021 | $21,344,000 | +19.6% | 79,536 | +0.3% | 0.24% | +8.7% |
| Q1 2021 | $17,843,000 | +1.7% | 79,275 | +0.3% | 0.22% | -11.7% |
| Q4 2020 | $17,549,000 | +39.3% | 78,999 | +35.0% | 0.25% | +0.8% |
| Q3 2020 | $12,597,000 | +98.0% | 58,500 | +62.6% | 0.25% | +108.5% |
| Q2 2020 | $6,363,000 | +12.6% | 35,981 | -11.9% | 0.12% | -8.5% |
| Q1 2020 | $5,653,000 | -10.5% | 40,842 | -0.8% | 0.13% | +16.2% |
| Q4 2019 | $6,318,000 | +6.9% | 41,167 | +0.6% | 0.11% | +5.7% |
| Q3 2019 | $5,909,000 | +11.8% | 40,912 | +10.6% | 0.10% | +16.7% |
| Q2 2019 | $5,286,000 | +9.0% | 36,987 | +0.7% | 0.09% | +7.1% |
| Q1 2019 | $4,849,000 | +39.7% | 36,732 | +9.2% | 0.08% | +23.5% |
| Q4 2018 | $3,470,000 | -36.8% | 33,649 | -33.4% | 0.07% | -12.8% |
| Q3 2018 | $5,491,000 | -13.5% | 50,532 | -21.5% | 0.08% | -8.2% |
| Q2 2018 | $6,350,000 | +18.1% | 64,352 | +17.2% | 0.08% | +13.3% |
| Q1 2018 | $5,378,000 | +5.8% | 54,929 | +0.3% | 0.08% | +7.1% |
| Q4 2017 | $5,082,000 | +19.2% | 54,754 | +10.1% | 0.07% | +11.1% |
| Q3 2017 | $4,265,000 | +11.4% | 49,717 | +9.6% | 0.06% | +6.8% |
| Q2 2017 | $3,830,000 | -1.1% | 45,380 | +0.3% | 0.06% | -10.6% |
| Q1 2017 | $3,871,000 | +42.5% | 45,255 | +29.7% | 0.07% | +32.0% |
| Q4 2016 | $2,716,000 | -0.2% | 34,894 | +0.5% | 0.05% | -7.4% |
| Q3 2016 | $2,721,000 | -43.8% | 34,706 | -27.7% | 0.05% | -39.3% |
| Q2 2016 | $4,845,000 | +15.1% | 47,974 | +8.1% | 0.09% | -1.1% |
| Q1 2016 | $4,208,000 | +16.3% | 44,364 | +13.9% | 0.09% | +18.4% |
| Q4 2015 | $3,618,000 | +11.2% | 38,953 | +2.0% | 0.08% | -1.3% |
| Q3 2015 | $3,255,000 | -45.0% | 38,205 | -44.8% | 0.08% | -28.7% |
| Q2 2015 | $5,919,000 | -1.0% | 69,151 | -1.8% | 0.11% | +0.9% |
| Q1 2015 | $5,980,000 | -37.5% | 70,441 | -36.9% | 0.11% | -24.1% |
| Q4 2014 | $9,561,000 | +12.6% | 111,547 | -0.2% | 0.14% | +10.2% |
| Q3 2014 | $8,494,000 | -2.1% | 111,798 | +1.5% | 0.13% | +0.8% |
| Q2 2014 | $8,675,000 | +0.5% | 110,184 | -4.3% | 0.13% | -4.5% |
| Q1 2014 | $8,632,000 | -2.3% | 115,087 | +0.6% | 0.13% | -5.0% |
| Q4 2013 | $8,835,000 | +4.3% | 114,443 | -6.3% | 0.14% | 0.0% |
| Q3 2013 | $8,469,000 | +12.9% | 122,168 | +3.1% | 0.14% | +7.7% |
| Q2 2013 | $7,500,000 | – | 118,482 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |